134 related articles for article (PubMed ID: 6320716)
1. A colorimetric assay for the measurement of the sensitivity of herpes simplex viruses to antiviral agents.
McLaren C; Ellis MN; Hunter GA
Antiviral Res; 1983 Nov; 3(4):223-34. PubMed ID: 6320716
[TBL] [Abstract][Full Text] [Related]
2. A rapid and automated colorimetric assay for evaluating the sensitivity of herpes simplex strains to antiviral drugs.
Langlois M; Allard JP; Nugier F; Aymard M
J Biol Stand; 1986 Jul; 14(3):201-11. PubMed ID: 3020058
[TBL] [Abstract][Full Text] [Related]
3. Methods for screening and profiling inhibitors of herpes simplex viruses.
Gong EY
Methods Mol Biol; 2013; 1030():303-13. PubMed ID: 23821277
[TBL] [Abstract][Full Text] [Related]
4. A microtiter virus yield reduction assay for the evaluation of antiviral compounds against human cytomegalovirus and herpes simplex virus.
Prichard MN; Turk SR; Coleman LA; Engelhardt SL; Shipman C; Drach JC
J Virol Methods; 1990 Apr; 28(1):101-6. PubMed ID: 2161417
[TBL] [Abstract][Full Text] [Related]
5. Low levels of herpes simplex virus thymidine- thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model.
Coen DM; Irmiere AF; Jacobson JG; Kerns KM
Virology; 1989 Feb; 168(2):221-31. PubMed ID: 2536980
[TBL] [Abstract][Full Text] [Related]
6. A rapid assay to screen for drug-resistant herpes simplex virus.
Tebas P; Scholl D; Jollick J; McHarg K; Arens M; Olivo PD
J Infect Dis; 1998 Jan; 177(1):217-20. PubMed ID: 9419192
[TBL] [Abstract][Full Text] [Related]
7. ELVIRA HSV, a yield reduction assay for rapid herpes simplex virus susceptibility testing.
Stránská R; Schuurman R; Scholl DR; Jollick JA; Shaw CJ; Loef C; Polman M; van Loon AM
Antimicrob Agents Chemother; 2004 Jun; 48(6):2331-3. PubMed ID: 15155247
[TBL] [Abstract][Full Text] [Related]
8. Virus drug-resistance: mechanisms and consequences.
Larder BA; Darby G
Antiviral Res; 1984 Apr; 4(1-2):1-42. PubMed ID: 6331303
[No Abstract] [Full Text] [Related]
9. Susceptibility of recent clinical isolates of herpes simplex virus to 5-ethyl-2'-deoxyuridine: preferential inhibition of herpes simplex virus type 2.
Teh CZ; Sacks SL
Antimicrob Agents Chemother; 1983 May; 23(5):637-40. PubMed ID: 6307130
[TBL] [Abstract][Full Text] [Related]
10. Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir.
Crumpacker CS; Schnipper LE; Marlowe SI; Kowalsky PN; Hershey BJ; Levin MJ
N Engl J Med; 1982 Feb; 306(6):343-6. PubMed ID: 6275267
[No Abstract] [Full Text] [Related]
11. Synergism between recombinant human interferon and nucleoside antiviral agents against herpes simplex virus: examination with an automated microtiter plate assay.
Moran DM; Kern ER; Overall JC
J Infect Dis; 1985 Jun; 151(6):1116-22. PubMed ID: 2987369
[TBL] [Abstract][Full Text] [Related]
12. Antiviral activity of Australian tea tree oil and eucalyptus oil against herpes simplex virus in cell culture.
Schnitzler P; Schön K; Reichling J
Pharmazie; 2001 Apr; 56(4):343-7. PubMed ID: 11338678
[TBL] [Abstract][Full Text] [Related]
13. Use of human monocytes in the evaluation of antiviral drugs: quantitation of HSV-1 cytopathic effects.
Lazdins J; Alteri E; Cook KW; Burgin C; Gangemi JD
Antiviral Res; 1990 Apr; 13(4):175-86. PubMed ID: 2166467
[TBL] [Abstract][Full Text] [Related]
14. Antiviral susceptibility of Herpes simplex viruses and its clinical correlates: a single center's experience.
Rabella N; Otegui M; Labeaga R; Rodríguez P; Margall N; Gurguí M; Prats G
Clin Infect Dis; 2002 Apr; 34(8):1055-60. PubMed ID: 11914993
[TBL] [Abstract][Full Text] [Related]
15. In vitro sensitivity to acyclovir in genital herpes simplex viruses from acyclovir-treated patients.
McLaren C; Corey L; Dekket C; Barry DW
J Infect Dis; 1983 Nov; 148(5):868-75. PubMed ID: 6313820
[TBL] [Abstract][Full Text] [Related]
16. Virus-drug resistance: thymidine kinase-deficient (TK-) mutants of herpes simplex virus. Therapeutic approaches.
de Clercq E
Ann Ist Super Sanita; 1987; 23(4):841-7. PubMed ID: 2837935
[No Abstract] [Full Text] [Related]
17. Comparison of two methods in the determination of the sensitivity of 84 herpes simplex virus (HSV) type 1 and 2 clinical isolates to acyclovir and alpha-interferon.
Brisebois JJ; Dumas VM; Joncas JH
Antiviral Res; 1989 Mar; 11(2):67-75. PubMed ID: 2543287
[TBL] [Abstract][Full Text] [Related]
18. Characterization of inhibitory action of concanamycins against herpes simplex virus.
Hayashi K; Kawauchi M; Nakai C; Sankawa U; Seto H; Hayashi T
Antivir Chem Chemother; 2001 Jan; 12(1):51-9. PubMed ID: 11437322
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous titration and phenotypic antiviral drug susceptibility testing for herpes simplex virus 1 and 2.
Tardif KD; Jorgensen S; Langer J; Prichard M; Schlaberg R
J Clin Virol; 2014 Nov; 61(3):382-6. PubMed ID: 25204613
[TBL] [Abstract][Full Text] [Related]
20. Antiherpesvirus activity in human sera and urines after administration of adenine arabinoside: in vitro and in vivo synergy of adenine arabinoside and arabinosylhypoxanthine in combination.
Champney KJ; Lauter CB; Bailey EJ; Lerner AM
J Clin Invest; 1978 Dec; 62(6):1142-53. PubMed ID: 219024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
